Safety Evaluation of Differing Schedules of Intravitreal Administration of rhuFab VEGF in Cynomolgus Monkeys for 2 Months

Toxicologist, 60 (1):97 (2001).

Published Date
O’Neill, C. A, Miller, P., Christian B. J., Leatherberry, G., Miller, J., Leedle, R., Dubeilzig, R. R., Albert, D. M., Beyer, J. C., Nork, T. M., Wabers, H., Neider, M., and Murphy, C. J.
Approved Therapy
Investigation Type
Development Phase
Therapy Class